Moderna Inc (MRNA)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 3,236,000 | 6,848,000 | 19,263,000 | 17,736,000 | 274,490 |
| Property, plant and equipment | US$ in thousands | — | — | 2,139,000 | 1,383,000 | 387,090 |
| Fixed asset turnover | — | — | 9.01 | 12.82 | 0.71 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $3,236,000K ÷ $—K
= —
The fixed asset turnover ratio for Moderna Inc has shown significant fluctuations over the years. In December 2020, the ratio was 0.71, indicating that the company generated $0.71 in revenue for every dollar invested in fixed assets. However, there was a substantial improvement in December 2021, with the ratio jumping to 12.82, suggesting a more efficient utilization of fixed assets to generate revenue.
In December 2022, the fixed asset turnover ratio remained relatively high at 9.01, demonstrating continued effectiveness in generating revenue from fixed assets. Unfortunately, there is missing data for December 2023 and December 2024, which limits the ability to assess the trend further.
Overall, the significant improvement in the fixed asset turnover ratio from 2020 to 2021 indicates enhanced operational efficiency and better asset utilization by Moderna Inc during those years. It would be important to monitor subsequent years' data to evaluate the sustainability of this improvement.
Peer comparison
Dec 31, 2024